The main aim of this study is to learn if fazirsiran reduces liver scarring (fibrosis) compared to placebo. Other aims are to learn if fazirsiran slows down the disease worsening in the liver, to get information on how fazirsiran affects the body…
- Investigator
- Ginger Clark
- Ages
- 18 Years - 75 Years
- Sexes
- All